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ABSTRACT 
In order to understand the dynamics of zoonotic disease transmission in the animal-human 
interface, a One Health approach is imperative. This study investigated the occurrence of the 
zoonotic pathogens Campylobacter spp., Salmonella spp. and rotavirus in fecal samples from 
free-ranging endangered toque macaques (Macaca sinica) and near threatened tufted gray 
langurs (Semnopithecus priam) in Sri Lanka. During March through May of 2015 samples were 
opportunistically collected at five sites in Sri Lanka where these primates come into close 
contact with humans. Standard culturing methods were used to screen for the bacteria and an 
ELISA-based quick-test was used to detect presence of type A human rotavirus. Bacterial 
sensitivity to selected antibiotics was analysed using VetMICTM broth microdilution panels. 
From the five sites, 98 samples were obtained. All samples tested negative for human type A 
rotavirus. All 40 samples from gray langurs were negative for Campylobacter spp. and 
Salmonella spp. Fifty-eight samples were collected from toque macaques, of which ten were 
positive for C. jejuni, four for C. coli and two for Salmonella Virchow. In vitro resistance to 
ampicillin, ciprofloxacin, nalidixic acid and tetracycline was detected in C. jejuni samples. All 
C. coli were in vitro resistant to ampicillin. The detected Salmonella Virchow were sensitive to
all the antibiotics tested for.
This study has detected C. jejuni, C. coli and Salmonella Virchow in fecal samples from 
endangered toque macaques in Sri Lanka with close human contact. The bacteria showed 
varying sensitivity to antibiotics and several C. jejuni were multidrug resistant. The presence 
of these bacteria in free-ranging animals could have implications both for non-human primate 
conservation and public health in Sri Lanka.  
SAMMANFATTNING 
Ett One Health perspektiv är viktigt när epidemiologi hos zoonotiska sjukdomar undersöks – 
både för bevarande av hotade arter och för folkhälsan. Denna studie undersökte förekomsten 
av de zoonotiska patogenerna Campylobacter spp., Salmonella spp. och rotavirus i träckprover 
från den utrotningshotade ceylonmakaken (Macaca sinica) och den nära hotade grå hulmanen 
(Semnopithecus priam) i Sri Lanka. Prover samlades in opportunistiskt under mars-maj 2015 
från fem platser i Sri Lanka där människor och dessa primater kommer i nära kontakt med 
varandra. Konventionella odlingsmetoder användes för att odla fram bakterier och ett ELISA-
baserat snabbtest användes för att detektera humant rotavirus typ A. Bakteriernas känslighet för 
utvalda antibiotika testades med VetMICTM testpaneler.  
Från de fem platserna samlades totalt 98 prover in. Alla prov var negativa för humant rotavirus 
typ A. Alla 40 prover från grå hulmaner var negativa för Campylobacter spp. och Salmonella 
spp. Totalt samlades 58 prover in från ceylonmakaker och av dessa var tio positiva för C. jejuni, 
fyra för C. coli och två för Salmonella Virchow. In vitro resistens mot ampicillin, ciprofloxacin, 
nalidixinsyra och tetracyklin påvisades hos C. jejuni. Alla C. coli var in vitro resistenta mot 
ampicillin. De två detekterade Salmonella Virchow var känsliga mot alla undersökta 
antibiotika.  
Denna studie har detekterat C. jejuni, C. coli och Salmonella Virchow i träckprover från 
utrotningshotade ceylonmakaker i Sri Lanka med nära kontakt med människor. Bakterierna 
uppvisade varierande känslighet mot antibiotika och flera C. jejuni var multidrogresistenta. 
Detektionen av dessa bakterier hos vilda djur kan ha konsekvenser både för bevarande av icke-
mänskliga primater och folkhälsan i Sri Lanka.  
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INTRODUCTION 
Zoonotic diseases – diseases with the ability to transmit between humans and other animals – 
are of increasing concern in today’s globalized world. Most emerging infectious diseases 
(EID’s) in recent years have originated in species other than humans (Pedersen and Davies, 
2009, Jones et al., 2008, Wolfe et al., 2007) and the emergence and re-emergence of diseases 
is closely linked to anthropogenic impact on ecosystems and wild animal species (Bengis et al., 
2004). Emerging diseases are not only a risk to human health, but also pose a great threat to the 
conservation of endangered species, since the viability of small populations can be gravely 
affected by the impact of disease outbreaks (World Organisation for Animal Health & 
International Union for the Concervation of Nature, 2014, Koendgen et al., 2008, Leendertz et 
al., 2006, Wallis and Lee, 1999). A fundamental understanding of infectious disease occurrence 
and epidemiology in wildlife is imperative to public health and the management and 
conservation of wildlife species (Gillespie et al., 2008, Leendertz et al., 2006).  
Bacteria of Campylobacter spp. and Salmonella spp. can cause disease in several species 
including humans and other primates (Ivanovic, 2012, Ngotho et al., 2006, Scarcelli et al., 2005, 
Nizeyi et al., 2001, Ohl and Miller, 2001). Human rotavirus causes mild to severe or deadly 
diarrheal disease in children in resource-poor settings (Martella et al., 2010, Parashar et al., 
2003, Dodet et al., 1997). The virus has been shown to be able to infect non-human primates 
under laboratory conditions (Chege et al., 2005, Zhao et al., 2005, Jiang et al., 2004) and 
seropositivity for rotavirus has been documented in free-ranging African non-human primates 
(Otsyula et al., 1996).  
Increasing antibiotic resistance in bacteria is a global matter, and resistance is increasingly 
common in both Salmonella spp. and Campylobacter spp. Already nearly 50 years ago the 
Swann Report was released, where the authors addressed the emergence of Salmonella spp. 
with multiple resistance to antibiotics. The authors concluded that this emergence was due to 
the misuse of antibiotics as growth promoters and other non-therapeutic uses of antibiotics in 
animal production (Swann et al., 1969). They also warned for the spread of resistance between 
different bacterial species. Acquired antibiotic resistance has since then indeed spread widely 
and rapidly and has been detected in bacteria from various ecosystems (Radhouani et al., 2014).  
The Democratic Socialist Republic of Sri Lanka is an island country off the southeast coast of 
India. It is considered one of the world’s 25 biological hotspots (Myers et al., 2000), with many 
plant and animal species being endemic to the island. Sri Lanka has also been predicted to be a 
country with moderate to high risk of transmission of zoonotic disease from wildlife to humans 
(Jones et al., 2008). Deforestation in recent years has led to habitat destruction and alterations 
for the country’s non-human primates and increasing human-to-non-human primate contact, 
which may pose a risk of disease transfer between the species. Previous studies on pathogens 
in non-human primates in Sri Lanka have covered the occurrence of parasites (Huffman et al., 
2013, Ekanayake et al., 2006, Dewit et al., 1991) and seroprevalence of dengue virus (De Silva 
et al., 1999). Still, little is known about which bacterial and viral pathogens circulate in the free 
ranging non-human primates in Sri Lanka.  
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Aim 
The primary aim of this study was to investigate the occurrence of enteric Campylobacter spp., 
Salmonella spp. and rotavirus in selected troops of free-ranging toque macaques (Macaca 
sinica) and tufted gray langurs (Semnopithecus priam thersites) in Sri Lanka. Secondly, the 
study aimed to assess the antibiotic sensitivity in the identified bacteria. 
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LITERATURE REVIEW 
Primates of Sri Lanka  
Alongside humans, five primate species are resident in the country of Sri Lanka: toque macaque 
(Macaca sinica), tufted gray langur (Semnopithecus priam thersites), gray and red slender 
lorises (Loris lydekkerianus et. tardigradus) and purple-faced langur (Trachypithecus vetulus). 
With the exception of the tufted gray langur and the gray slender loris, all are endemic to the 
island (IUCN, 2015). All Sri Lankan non-human primates show decreasing population trends 
due to habitat encroachment and alteration through human activities such as agriculture and 
biological resource use (IUCN, 2015). The country no longer has any intact forest landscapes; 
the total closed-canopy cover has decreased from 84 % in 1881 to about 30 % in 2005 and 
112,000 Ha of dense forest has been lost between 2001 and 2014, despite large areas being 
protected as national parks (Hansen et al., 2013, Nahallage et al., 2008).  
Due to the fragmentation of their habitat, primates are foraging on farms and in urban areas. 
The increasing contact between humans and other primates has lead to a human-primate conflict 
(Nahallage and Huffman, 2013, Nahallage et al., 2008). Interview studies by Nahallage and 
Huffman (2013) revealed that the majority of the interviewees perceived the non-human 
primate populations to have grown in recent years. Most also stated that the primates raid crops. 
Another study showed that the human-primate conflict in Sri Lanka is relatively temperate 
considering the high level of deforestation and human-primate contact (Nekaris et al., 2013). 
At temples and holy places, primates are allowed to roam and forage relatively undisturbed, 
due to religious beliefs prohibiting disturbance of the monkeys (Nahallage and Huffman, 2013). 
The temples have vast numbers of local and international visitors every day and food is often 
offered by worshipers to later be consumed by primate troops in the proximity. The troops are 
well habituated and often come into direct contact with humans.  
Through the consumption of disposed of food, the non-human primates are exposed to the same 
foodborne infectious agents as humans. Suboptimal water treatment and poor sanitation makes 
water another important vehicle in disease transmission. In analyses of bottle, well and surface 
water in Sri Lanka the presence of many potentially pathogenic enteric bacteria was detected, 
as well as levels of total- and fecal coliforms exceeding the WHO permissible levels 
(Mannapperuma et al. (2013). The increasing contact between humans and non-human primates 
serves as an interface for zoonotic transmission of viruses, bacteria and parasites, which 
previously has been reported in both non-human primates in Sri Lanka as well as in other parts 
of the world (Kooriyama et al., 2013, Schaumburg et al., 2012, Nagel et al., 2012, Kowalewski 
et al., 2011, Pedersen and Davies, 2009, Koendgen et al., 2008, Rwego et al., 2008, Ekanayake 
et al., 2007, Goldberg et al., 2007, Ekanayake et al., 2006, Ekanayake et al., 2004).  
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The present study focused on screening for potentially zoonotic pathogens in fecal samples 
from tufted gray langurs and toque macaques, due to them being easily accessible in locations 
with an extensive human-to-non-human primate interface, namely at temples and historical 
sites.  
Tufted gray langur (Semnopithecus priam 
thersites) 
The tufted gray langur (Figure 1) is a diurnal, semi-
terrestrial, mainly folivorous species found in 
southern India and in Sri Lanka’s dry zone areas 
(IUCN, 2015). It is listed as near threatened and their 
numbers have decreased with at least 50 % in the 
past three generations. 
Langurs are colobine monkeys and have a digestive 
system that entails both foregut and hindgut 
fermentation (Map of Life, 2015, Stewart et al., 
1987). The foregut consists of two indiscrete 
fermentation chambers and the colon is segmented 
which allows for digesta being withheld for a 
prolonged time. This unique trait makes the colobine 
feeding behaviour different from more omnivorous 
relatives, such as macaques.  
Toque 
macaque (Macaca sinica) 
The toque macaque (Figure 2) is a diurnal, mainly 
arboreal, frugivorous primate. It resides in various 
forest types in Sri Lanka, as well as in urban 
environments (IUCN, 2015). 
The species is endangered and numbers have 
decreased by over 50 % in the past three generations 
(IUCN, 2015). Toque macaques are not only 
threatened by loss of habitat, but they are also 
exploited in the pet industry where they are captured 
to be used for entertainment (Nahallage and Huffman, 
2013) as well as being used as target practice by the 
army (IUCN, 2015). The species is protected under 
the Convention on International Trade in Endangered 
Species of Wild Fauna and Flora (CITES), but is the 
only endemic primate species to not be protected by Sri Lankan law.Figure 2. A toque macaque carrying an 
infant in Polonnaruwa. Photo by author. 
Figure 1. A tufted gray langur in 
Kataragama. Photo by author. 
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Campylobacter spp.  
Campylobacter spp. are small, rapidly mobile, Gram-negative, spiral shaped microaerophilic 
rods. Campylobacteriosis is the number one cause of infectious bacterial gastrointestinal 
disease in developed countries and the most reported zoonosis in Europe (European Food Safety 
Authority, 2015, Silva et al., 2011, Butzler, 2004). Human campylobacteriosis is characterized 
by an often self-limiting gastroenteritis and sometimes colitis with abdominal cramps, diarrhoea 
and fever (Butzler, 2004). In many developing countries, campylobacteriosis is hyper endemic 
in young children, who generally acquire immunity after clearing the infection. However, the 
disease may lead to malnutrition (Alfredson and Korolik, 2007, Butzler, 2004). Campylobacter 
jejuni and C. coli are the species within the Campylobacter genus of greatest public health 
concern, causing the majority of cases in humans, with C. jejuni being the major causative agent 
(Aarestrup and Engberg, 2001). Infections with certain C. jejuni strains have been strongly 
linked to the development of Guillain-Barré syndrome, an autoimmune polyneuropathy causing 
acute flaccid paralysis (Nachamkin et al., 1998).  
Most cases of campylobacteriosis are sporadic, but outbreaks occur. The bacteria is often 
foodborne, causing disease after consuming contaminated foods, most often animal products. 
Up to 80% of all human cases of campylobacteriosis in the EU may be linked to chicken as a 
reservoir of the bacteria (European Food Safety Authority, 2010) and human-to-human 
infections are rare (Aarestrup and Engberg, 2001). In 2014, almost 237,000 human cases were 
confirmed in Europe (European Food Safety Authority, 2015). The most affected age group are 
children <5 years of age (European Food Safety Authority, 2012b). Human stool may contain 
bacteria for up to seven weeks after a Campylobacter infection (Butzler, 2004), meaning that 
grossly normal appearing stool may contain infectious bacteria. Generally, asymptomatic 
infection is uncommon in developed countries. In an Australian study the prevalence of 
Campylobacter spp. was 0.1 % in asymptomatic individuals who were screened for 
gastrointestinal pathogens (Hellard et al., 2000) A prospective study reported transmission of 
Campylobacter spp. from broiler chicken to Swedish abattoir workers who did not develop 
symptoms of disease (Ellstrom et al. (2014).  
Campylobacter spp. have previously been detected globally in both captive and free-ranging 
non-human primates (Table 1) (Stirling et al., 2008, Ngotho et al., 2006, Misawa et al., 2000). 
Asymptomatic carriers are common and clinical disease may include bloody diarrhoea and 
dehydration (Baskin, 2008). Rhesus macaques are used as model animals for experimental 
infection with Campylobacter spp. in lab environments, where they develop clinical illness 
(Gardner and Luciw, 2008, Islam et al., 2006). Taema et al (2008) reported Campylobacter spp. 
in 15% of gastroenteritis cases in non-human primate individuals housed at London Whipsnade 
Zoo. In a Brazilian study, Scarcelli et al (2005) found four subtypes of the bacteria being shared 
between humans and other primates (Callitrix spp.), suggesting zoonotic potential. The sampled 
primates were all captive animals that had chicken as a part of their diet (Scarcelli, 2015) which 
may indicate that also non-human primates may be infected by foodborne Campylobacter spp.  
In Sri Lanka, a study carried out at a children’s referral hospital showed that Campylobacter 
spp. represented 15 % of the bacterial isolates from gastroenteritis cases in children <12 years 
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of age (Patabendige et al., 2011). Between 2004-2007, human stool samples analysed at the 
Medical Research Institute, Colombo, Sri Lanka had a percentage of Campylobacter-positivity 
of 1.6-6.7 % per year (Cooray and Perera, 2007). Another study reported C. jejuni in food where 
C. jejuni was detected in 26.7% and 55 % of raw chicken and milk samples respectively 
(Munasinghe et al., 2002). In broiler flocks, the incidence of Campylobacter spp. has been 
shown to be over 70 % (Kottawatta et al., 2007). 
Salmonella spp. 
Salmonella spp. is a large bacterial genus within the family Enterobacteriaceae. They are 
Gram-negative, facultative anaerobic, non-spore-forming, and often motile rods. Globally they 
are found in the environment and the gastrointestinal tract of various animal species (World 
Health Organization, 2013).  
Human salmonellosis is mostly a self-limiting disease causing acute fever, abdominal pain, 
diarrhoea, nausea and vomiting, but the disease may also be asymptomatic (Hellard et al., 
2000). In the EU 88,715 cases of salmonellosis were reported in 2014, which makes it the 
second most reported zoonosis after campylobacteriosis (European Food Safety Authority, 
2015). The disease is usually more severe in children, the elderly or immunocompromised 
individuals and may be deadly due to severe dehydration, electrolyte imbalance or sepsis – 
especially after infection with certain serovars such as S. Typhi, which causes typhoid disease. 
Children < 5 years of age have a higher incidence of infection than other age groups (CDC, 
2015). Outbreaks may occur, but up to 80 % of Salmonella cases are sporadic (World Health 
Organization, 2013). Following infection, the stool may contain bacteria for up to seven weeks 
(Hohmann, 2001). A possible complication to salmonellosis is reactive arthritis that may 
become chronic. Antibiotic treatment is recommended in the case of life-threatening disease or 
to very young or elderly individuals, where fluoroquinolones, 3rd generation cephalosporins or 
macrolides are the drugs of choice. Salmonellosis in humans is most often caused by serovars 
of S. enterica sp. enterica. Within the subspecies, the bacteria are further classified into serovars 
depending on their O-, H-, and Vi-antigens according to the Kauffmann-White classification 
system (Kauffman, 1961). Over 2,500 serovars have been identified of S. enterica sp. enterica 
and out of these <500 have zoonotic potential (European Food Safety Authority, 2012a). 
Salmonella Enteritidis and S. Typhimurium are identified in the majority of human cases and 
the majority of infections are food-borne, often via chicken or eggs from chicken (Dunkley et 
al., 2009).  
Just as in humans, S. Enteritidis and S. Typhimurium cause most cases of salmonellosis in non-
human primates. Cases can be both sporadic and epizootic. Individuals can carry the bacteria 
asymptomatically, but the disease can also have a severe course with enteritis and colitis, 
resulting in bloody diarrhoea, fever, sepsis and death. The bacteria may also cause abortions, 
osteomyelitis and arthritis (Abee et al., 2012, Baskin, 2008). Cases of salmonellosis have been 
reported in both free-ranging and captive non-human primates (Table 1; (Good et al., 1969).  
Salmonella spp. has been reported in samples from broiler chicken and various water sources 
in Sri Lanka (Jayatilleke et al., 2015, Mannapperuma et al., 2013). An outbreak of salmonellosis 
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after consumption of monkey meat has also been reported (Lamabadusuriya et al., 1992). One 
of nine infected died after consuming the flesh and internal organs of a monkey who had been 
found dead. Later several monkeys were found dead in the same area and the authors speculated 
whether the consumed monkey in fact died from salmonellosis, or if the carcass had been 
contaminated.  
Table 1. Examples of studies where analyzing fecal samples from non-human primates has detected 
Campylobacter spp. and Salmonella spp.  
Location Species 
Positive samples (%) 
Reference 
Campylobacter Salmonella
Tanzania Chimpanzee (Pan 
troglodytes) 
341; 882 * - 
Kaur et al (2011) 
01; 532 - 
Madagascar Ring-tailed lemur (Lemur 
catta) 
0 0 
Villers et al (2008) 
USA Ring-tailed lemur (Lemur 
catta) 
16 0 
Brazil Marmoset (Callitrix spp.) 5 - Scarcelli et al (2005) 
Uganda  Mountain gorilla (Gorilla 
berengei berengei) 
19 13 
Nizeyi et al (2001) 
8 4 
Trinidad Multiple  0 2.5 Adesiyun et al (1998) 
Peru Multiple  20.9 - Tresierra-Ayala and 
Fernandez (1997) Multiple  31.9 - 
1Culture; 2PCR; *56 samples originating from 29 individuals 
Antibiotic resistance 
Molecules with antibiotic properties are produced naturally by a vast number of 
microorganisms and it is thought that antibiotic substances have existed for over 500 million 
years. Resistance to antibiotics emerges through bacterial genes that code for a variety of 
protective mechanisms: changes in the target structure, production of enzymes that change the 
antibiotic substance and makes it harmless, active efflux pumping or changes in transport 
channels that limits the antibiotics’ access to the bacteria. These mechanisms behind antibiotic 
resistance tend to have a fitness enhancing effect for bacteria also in natural environments. For 
example: efflux pumps used by soil bacteria to expel various toxic compounds from the cell are 
a common cause of multi-drug resistance in pathogens. Antibiotic resistance genes are 
evolutionarily old; β-lactamases are dated back to 2 billion years ago. However, since the 
introduction of antibiotics in human medicine and animal production, the selection pressure for 
bacterial strains harbouring resistance genes has massively increased (Allen et al., 2010).  
Resistance genes can be acquired either by mutations or through horizontal gene transfer where 
genes coding for resistance mechanisms are transferred from one bacterium to another in mobile 
genetic elements. Soil or animal gut bacteriomes represent melting pots where genetic material 
is continuously interchanged. Thus, naturally occurring mechanisms in bacteria may under the 
right selection pressure and gene transfer between bacteria be displayed as resistance to 
 13
therapeutic drugs in pathogenic bacteria (Allen et al., 2010). Already in the Swann Report the 
authors highlighted the danger in antibiotic resistance being transmissible between different 
bacterial populations (Swann et al., 1969). 
In Sri Lanka, there is currently no national policy limiting the use of antibiotics. Within animal 
agriculture and aquaculture the use of antibiotics as growth promoters is still practiced (SLCM, 
2014, Patabendige et al., 2011) and antibiotic resistance is an increasing problem in the country. 
According to Patabendige et al (2011), compliance to existing local policies on the use of 
antibiotics is “variable from satisfactory to poor”. In a report on the Sri Lankan national 
surveillance of antimicrobial resistance by the Sri Lankan College of Microbiology (SLCM, 
2014) the overall data according to the authors indicated that “antibiotic resistance is 
alarmingly frequent”. The SLCM urged for a national antibiotic policy being developed with 
the participation of the Ministry of Livestock and Ministry of Health, in order to promote a 
more rational use of antibiotic drugs in Sri Lanka.  
Antibiotic resistance in Campylobacter spp. 
Campylobacter spp. have the ability to acquire genetic material from other bacteria and known 
antibiotic resistance determinants are thought to have been transferred from Gram-positive 
cocci (Alfredson and Korolik, 2007). Macrolides and fluoroquinolones have traditionally been 
used for treating complicated, systemic, or long-lasting campylobacteriosis. Intravenous 
treatment with aminoglycosides is also an option for systemic infections (Aarestrup and 
Engberg, 2001). However, resistance to these drugs, particularly fluoroquinolones, has 
increased dramatically in recent years, with C. coli showing a higher degree and prevalence of 
resistance than C. jejuni (Aarestrup and Engberg, 2001). Resistance to macrolides and 
fluoroquinolones have been shown to be due to chromosomal mutations changing the drug-
sensitive target (Aarestrup and Engberg, 2001). 
The emergence of antibiotic resistant Campylobacter strains has been clearly associated to 
global use of antibiotics in animal production (Alfredson and Korolik, 2007, Aarestrup and 
Engberg, 2001). The increase in resistance correlates strongly to the varying use of antibiotics 
in animal production in different countries. For example, in Australia the use of 
fluoroquinolones in animal production is banned and the resistance in C. jejuni and C. coli low. 
In Denmark, resistance to antibiotics in bacterial isolates have decreased since certain 
antibiotics have been banned from use in food production. In contrast, in countries such as 
Spain, Taiwan and Germany, resistance is prevalent – which correlates to the use of the drug in 
animal production (Alfredson and Korolik, 2007). In the Netherlands, the introduction of 
fluoroquinolones for veterinary use in food production led to a concurrent increase in 
Campylobacter resistance against the drug where the fluoroquinolone resistance in isolates 
from broilers increased from 0 to 29% in 10 years (Aarestrup and Engberg, 2001, Endtz et al., 
1991).  
Currently the macrolide drug erythromycin is the drug of choice in treatment of clinical 
campylobacteriosis, since the prevalence of resistance is still relatively low (Gibreel and Taylor, 
2006). However, indications are strong, especially in developing countries, that resistance is 
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evolving rapidly also to this drug, particularly in C. coli cultured from pigs. It is likely that this 
is due to the use of the drug tylosine – another macrolide – both therapeutically and as a growth 
promoter (Aarestrup and Engberg, 2001). In Sri Lanka, multiple resistance in Campylobacter 
spp. from human samples has been reported (Cooray and Perera, 2007).  
Antibiotic resistance in Salmonella spp. 
Emerging antibiotic resistance in Salmonella spp. in livestock was reported already in the 
Swann report (Swann et al., 1969). The authors urged for restrictions on the use of antibiotics 
in animal agriculture to slow the emergence of resistance to clinically relevant antibiotics. 
Antibiotic resistance in Salmonella spp. in non-human primates was reported in the same year 
(Good et al., 1969). Resistance to antibiotics in non-typhoidal Salmonella spp. increased in 
human clinical samples in the USA during the 1990’s and since then there have been several 
reports of resistance to enrofloxacin, nalidixic acid, ciprofloxacin and extended spectrum 
cephalosporins (Hohmann, 2001). These are drugs that are used to treat life-threatening 
salmonellosis, which makes the development of resistance highly concerning. The prevalence 
of resistant strains is increasing, particularly in Asia. The isolation rate of non-typhoidal 
Salmonella spp. is relatively low in Sri Lanka (Jayatilleke et al., 2015), but cases of Salmonella 
spp. resistant to fluoroquinolones and chloramphenicol have been reported (Karunanayake and 
Atukorala, 2004, Fernando, 1993) and in 1999 43 % of all human isolates were resistant to 
chloramphenicol (Karunanayake and Atukorala, 2004).  
Rotavirus  
The rotavirus is a dsRNA virus with a genome consisting of 11 segments in a double-shelled 
capsid. Antigen proteins classify the viruses into groups, of which group A is of highest public 
health concern (Martella et al., 2010, Haffejee, 1995). There are also indications that group A 
rotaviruses have zoonotic potential (Martella et al., 2010). Globally, rotavirus infections cause 
gastrointestinal disease of varying severity and leads to the death of about 440,000 children 
under the age of 5 every year. Eighty-two per cent of deaths due to rotavirus infections are 
children in resource-poor countries, making the disease an important contributor to childhood 
mortality in these countries (Parashar et al., 2003). However, globally, children in developed 
countries who come from financially affluent backgrounds have higher rotavirus diarrhoea 
prevalence than children in developing countries. Infections can also be asymptomatic, most 
often in individuals < 6 months or > 6 years of age (Haffejee, 1995).  
Primates can be infected by simian rotaviruses (Wang et al., 2007), which are closely related to 
human rotaviruses. However, under laboratory conditions, vervet monkeys (Chlorocebus 
pygerythrus), macaques and olive baboons (Papio anubis) have been infected with human 
viruses (Gardner and Luciw, 2008, Chege et al., 2005, Zhao et al., 2005). Otsyula et al (1996) 
showed that the seropositivity for anti-rota antibodies in wild caught African non-human 
primates was not significantly different from primates bred in captivity. Therefore, the authors 
concluded that rotaviruses are likely endemic in both wild and captive non-human African 
primates. In Brazil, Souza et al (2012) screened fecal samples from several free-ranging 
primates for enteric viruses including rotavirus type A, but found no positive samples.  
 15
MATERIALS AND METHODS 
Study animals and collection sites  
The toque macaque and tufted gray langur were selected as study species since several troops 
reside in close proximity to human populations in Sri Lanka, leading to a potential for diseases 
being transmitted between humans and the other primates. Samples were collected at five 
locations (Fig 2; Table 2) in Sri Lanka during March-May 2015. All samples were collected 
from urban primate troops that were resident on or near temple sites or archaeological sites 
frequented by local and international visitors who worship or sightsee.  
Sampling 
Primate troops were observed at a distance and fecal 
specimens were sampled opportunistically from the 
ground, when possible immediately after defection. 
Freshness of the specimen was evaluated on the basis of 
moistness and consistency. The presence of 
macroscopically visible blood or mucus was also recorded 
for each specimen. 
Fecal specimens that were found fresh in the presence of a 
troop of the target species were assumed to originate from 
that troop. To minimize risk of double sampling of the same 
individual, no specimens within two meters of each other 
were sampled, unless they were directly observed 
defecations from different individuals. When a specimen 
was not fresh (dry feces), it was not sampled. If no troop 
had been observed in the proximity, specimens were not 
sampled, regardless of freshness.  
Each selected specimen was assigned a unique number and sampled in 
duplicates directly on the ground by using the Copan FecalSwabTM (Copan 
Diagnostics Inc.) containing a modified, liquid Cary-Blair transport 
medium. Specimens were sampled from the centre, or from the top of the 
specimen to minimize the risk of contamination with soil bacteria. All 
samples were immediately stored in a cooler box with ice packs keeping 
refrigerator temperature (approx. +5°C) as controlled by a digital 
thermometer. At the end of each collection day samples were stored in a refrigerator until the 
time of analysis.  
To detect the presence of occult blood in sampled specimens the Hemoplus ® test (Sarstedt) 
was used. Hemoplus ® test kits were prepared in the field by placing small amounts of faeces 
in the test kits, which were transported and stored in room temperature until performing the test 
by adding reagent. The Hemoplus ® test was performed after the sample kits had completely 
dried, according to the manufacturers instructions. 
Figure 2. The five sites selected for 
collection of fecal samples screening
for Campylobacter spp. and 
Salmonella spp. in toque macaques 
and tufted gray langurs:
Anuradhapura, Polonnaruwa,
Kandy, Kataragama and
Udawalawe.  
Illustration by Sara Hägglund 
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Microbiological analyses 
All bacterial and viral analyses were initiated within two days of sampling. Initial fecal 
culturing was performed at the laboratory of the Department of Medical Microbiology, Faculty 
of Medicine, University of Kelaniya, Ragama, Sri Lanka. Typing and resistance profiling was 
performed at The National Veterinary Institute (SVA), Uppsala, Sweden.  
Salmonella spp. 
The detection of Salmonella spp. was performed using a modified NMKL (Nordisk 
metodikkommitté för livsmedel) no. 71 method. Samples were enriched in two steps using 
Buffered peptone water and Rappaport-Vassiliadis soya peptone broth. After enrichment, 
samples were inoculated to the selective media Xylose-Lysine-Desoxycholate and brilliant 
green agars and incubated overnight. When needed, multiple inoculations were thereafter 
performed to obtain pure cultures. 
Colonies that were suspected positive based on macroscopic and microscopic appearance 
following Gram staining were inoculated to blue agar and incubated overnight. Lactose 
negative pure cultures were stored in serum broth with 15 % glycerol in -20°C, for later 
transport on dry ice to SVA. Before transport, culture broth was also inoculated to blood agar 
and incubated for 48 h at 37°C. The cultures were swabbed and transported in Amies medium 
(Citotest CitoswabTM Amies) in a Styrofoam box with ice packs.  
Campylobacter spp. 
Samples were cultured using a modified ISO-method for the detection of Campylobacter spp. 
The sample swabs were placed in 5 ml Preston broth and incubated overnight in modified 
atmosphere at 41.5°C using an airtight vial and CampyGenTM atmosphere generator packs 
(Thermo Fisher Scientific). Thereafter, broth was inoculated to Campylobacter blood free 
selective medium (mCCDA) agar and incubated for 44-72 h. Macro- and microscopically 
typical colonies were inoculated to blood agar and incubated 48-72 h. Colonies were Gram 
stained and examined microscopically, and tested with oxidase and catalase tests. Colonies 
were then stored in -20°C in serum broth with 15 % glycerol for later transport to SVA on dry 
ice. Before transport culture broth was also inoculated to blood agar and incubated for 72 h in 
modified atmosphere at 41.5°C. Colonies were swabbed with a transport swab in Amies 
charcoal medium (Copan, TransystemTM Amies W/CH 114C.), in a Styrofoam box with ice 
packs. 
Species identification and antibiotic sensitivity testing   
At SVA, species conformational tests were performed using Matrix-Associated Laser 
Desorption/Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS), biochemical 
methods – including Hippurate hydrolysis for Campylobacter spp. – and serotyping with 
antisera to determine Salmonella species and serovar according to the Kauffman-White 
classification system (Kauffman, 1961). The strains were tested for antibiotic resistance using 
VetMIC™ panel analysis systems (National Veterinary Institute, Sweden). The VetMICTM 
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system is based on broth microdilution, testing antibiotic susceptibility by obtaining the in vitro 
minimum inhibitory concentration (MIC). The VetMICTM panels Camp EU, CLIN GN and 
GN-mo (version 4) were used for the determination of MIC for selected antibiotic substances. 
Defined strains of E. coli and C. jejuni were used as batch quality control organisms for each 
run. Epidemiological cut-off (ECOFF) values for comparison with MIC-values were obtained 
from the European Committee on Antimicrobial Susceptibility Testing (European Committee 
on Antimicrobial Susceptibility Testing). Strains with MIC exceeding the ECOFF-value for an 
antibiotic were considered in vitro resistant to the substance. 
Rotaviruses 
Analyses for the detection of rotavirus group A was performed using the Combi-Strip Dipstick 
system (Coris Bioconcept) within 48 hours of sample collection. The Cary-Blair transport 
medium was thoroughly vortexed and 200 μL of sample-containing medium was diluted 1:1 
with dilutant of the Combi-Strip system, after which the dipstick was allowed to react with the 
solution. Positive and negative controls from the manufacturer were used for batch quality 
control. The Coris Bioconcept dipstick system has previously been validated for analysis of 
samples transported with the Copan FecalSwabTM (Castriciano and Leclipteux, 2009). 
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RESULTS 
From the five sites, 98 samples were obtained, of which 58 were from toque macaques and 40 
from tufted gray langurs (Table 2). Seven out of 58 toque macaque samples and 17 out of 40 
gray langur samples were from observed defecations.  
All samples tested negative for human type A rotavirus. Salmonella spp. and Campylobacter 
spp. were only detected in samples from toque macaques; all langur samples were negative for 
both bacteria. Out of 58 toque macaque samples, 16 were positive on culture for either 
Salmonella spp. or Campylobacter spp.; two samples were positive for Salmonella enterica 
enterica serovar Virchow, ten for C. jejuni and four for C. coli. All four C. coli and one C. 
jejuni strain were Hippurate-negative, whereas the remaining nine were Hippurate-positive.  
Table 2. Fecal samples from tufted gray langurs and toque macaques collected in five locations in Sri 
Lanka tested for Campylobacter spp. and Salmonella spp. by culturing  
Location Total samples Gray langur
Toque macaque 
 Positive samples 
 n n n Salmonella Virchow C. jejuni C. coli
Anuradhapura 30 17 13  4  
Kandy 19 N/A 19 2 4 4 
Polonnaruwa 21 9 12  2  
Kataragama 14 14 N/A - - - 
Udawalawe 14 N/A 14    
 98 40 58 2  10 4 
N/A = not applicable since the species was not resident at location. 
Occult blood occurrence 
None of the samples that were positive for either bacterium were positive for macroscopically 
visible mucus or blood. Seven out of 58 toque macaque samples were positive for occult blood. 
Six out of seven were positive for either bacterium. None of the samples from tufted gray langur 
were positive for occult blood.  
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Antibiotic resistance 
The Salmonella Virchow strains were sensitive to all antibiotics tested for. Antibiotic resistance 
was detected in 4 out of 10 C. jejuni (Table 3). One of which was resistant to ampicillin only; 
one to ampicillin, ciprofloxacin, nalidixic acid and tetracycline; two to ciprofloxaxin, nalidixic 
acid and tetracycline. All strains were susceptible to chloramphenicol, erythromycin, 
florfenicol, gentamicin and streptomycin. All C. coli were highly resistant to ampicillin but 
susceptible to ciprofloxacin, chloramphenicol, erythromycin, florfenicol, gentamicin, nalidixic 
acid, streptomycin and tetracycline. MIC-distributions for colistin and sulfamethoxazole are 
reported for both Campylobacter spp. ECOFF-values for these antibiotics are not determined 
for C. jejuni and C. coli, so ECOFF-values for E. coli was used for comparison with the 
determined MIC-values.  
Table 3. MIC for Campylobacter spp. cultured from toque macaque fecal samples. ECOFF-values are 
marked with a red vertical line for each antibiotic. The vertical blue line represents the ECOFF-value 
for E.coli 
Species MIC distribution 
C. jejuni 
(n=10) 
Ampicillin 
≤0.5 1 2 4 8 16 32 64 >64 
6  2    1 1  
Ciprofloxacin 
≤0.12 0.25 0.5 1 2 4 8 16 >16 
6 1      2 1 
Nalidixic acid 
≤0.5 1 2 4 8 16 32 64 >64 
  1 6     3 
Tetracycline 
≤0.5 1 2 4 8 16 32 64 >64 
7       1 2 
Sulfamethoxazole 
≤4 8 16 32 64 128 256 512 >512 
   1 5 3 1   
Colistin     
≤0.25 0.5 1 2 >2     
    10     
C. coli 
(n=4) 
Ampicillin 
≤0.5 1 2 4 8 16 32 64 >64 
        4 
Sulfamethoxazole 
≤4 8 16 32 64 128 256 512 >512 
   2 2     
Colistin     
≤0.25 0.5 1 2 >2     
 1 3       
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DISCUSSION 
In a globalized world battling increasing problems with emerging zoonotic diseases and a 
rapidly emerging bacterial resistance to various antibiotic substances, an understanding of the 
characteristics and epidemiology of diseases is essential. The present study has detected the 
zoonotic enteric bacteria C. jejuni, C. coli and S. Virchow in free-ranging toque macaques in 
Sri Lanka. Due to the close contact between humans and other primates, this indicates a 
potential for disease transmission between humans and other primates, which could have 
consequences for the conservation of these endangered and endemic non-human primates as 
well as for public health in the country. The detected bacteria do not always cause disease in 
non-human primates, but have been detected as causative agents to fatal illness, which is a 
reason for concern (Abee et al., 2012, Baskin, 2008, Ngotho et al., 2006). In addition, 
campylobacteriosis and salmonellosis cause problems in the human population in Sri Lanka, as 
well as causing gastrointestinal disease in visiting tourists.  
According to Coorey and Perera (2007), the vehicle for human campylobacteriosis in Sri Lanka 
is still unknown, although one study has reported C. jejuni in milk and chicken meat 
(Munasinghe et al., 2002). It can be assumed that poultry plays a role as an important vehicle 
for both Salmonella spp. and Campylobacter spp., as in many other countries. No reports have 
been found on the epidemiology of Salmonella spp. in the human population in Sri Lanka. 
There is however a report of Salmonella spp. being present in both surface- and bottled water 
in Sri Lanka (Mannapperuma et al., 2013) , which may serve as a source of infection for both 
humans and non-human primates.  
The proportion of positive toque macaque samples for C. jejuni and C. coli in this study is 
similar previous findings in studies on non-human primates (Table 1). As in other studies, the 
prevalence of Salmonella spp. in the populations is likely low and can be estimated to ≤5.2 % 
(95 % CI) in the toque macaque population (Hanley and Lippman-Hand, 1983). In the gray 
langur population the prevalence for either bacterium can be estimated to be ≤7.5 % (95 % CI). 
With the limited sample size one must be cautious to draw conclusions about the true 
prevalences in both tufted gray langur and toque macaque populations. The true prevalences 
may in fact be similar despite the lack of detected positive langur samples in this study. 
However, the difference between the two species is interesting considering the differences 
between the macaque and langur digestive systems. The langur is a foregut fermenter, with a 
higher level of efficient bacteriolytic lysozyme in the stomach as compared to many other 
mammals (Stewart et al., 1987). The lysozyme is like that of bovines, which digests many 
bacteria efficiently before they can pass into the true stomach and remainder of the digestive 
canal. This may cause the tufted gray langurs to be less susceptible to oral infection by the 
investigated bacteria than toque macaques. Further studies with more samples from the two 
species in Sri Lanka could shed light on this phenomenon and whether the presence of a more 
efficient lysozyme could indeed have an effect on the gastrointestinal health of the tufted gray 
langurs as compared to the toque macaques sharing the same environment. 
Although no human rotavirus type A was detected in the collected samples the prevalence may 
be ≤5.2 % in the toque macaque (95 % CI) and ≤7.5 % in the tufted grey langur (95 % CI) 
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populations (Hanley and Lippman-Hand, 1983). Since the virus is known to affect young 
individuals in many species the lack of positive samples is not unexpected (Martella et al., 
2010). The likelihood of opportunistically acquiring samples specifically from infants is very 
low with a small sample size. A sample collection targeted exclusively for samples from young 
individuals would have to entail more invasive methods where individuals would be directly 
targeted, likely demanding direct contact and disturbance to the animals. The benefit of more 
invasively investigating the rotavirus status in the young in free-ranging primate troops is 
questionable compared to the cost of disturbing the troop and infant-mother bonds.  
The presence of occult blood was higher in samples that were positive for either bacterium than 
in those that were negative on culturing. Although bloody diarrhoea may be a part of the clinical 
signs in both campylobacteriosis and salmonellosis (Ivanovic, 2012, Baskin, 2008), the 
presence of occult blood does not detect a specific disease. In addition, none of the samples 
where occult blood was detected were in fact from diarrhoeic specimens. The health status of 
the sampled individuals was not known due to non-invasive collection and the samples mostly 
originating from unknown individuals. One individual in the Kandy area was observed 
vomiting and another individual in the same troop had an appearance of being ill (ungroomed, 
dirty, was sleeping while the troop was foraging). It is unknown if any of the samples originated 
from these individuals, since they were not observed defecating. However, the two samples that 
were positive for Salmonella Virchow and four of the C. jejuni-positive samples originated in 
this troop, which may indicate that these bacteria had an effect on the health of the animals in 
the troop.  
Standard culturing methods were used to detect bacteria in this study. The sensitivity for 
bacterial culturing is variable depending on the method and sampling conditions. Also, the 
handling of samples until start of analysis may affect the result regardless of which method is 
chosen, as well as how fresh specimens are at the time of sampling. It is possible that the true 
number of positive samples for the respective bacterium is higher than reported here. Ideally, 
all specimens should have been sampled directly after observed defecations to ensure freshness 
and minimizing the risk of overgrowth with non-target organisms or death of the target bacteria 
in the sample. However, selective growth media and modified atmosphere was used to supress 
overgrowth of competing agents. Other methods such as PCR-based methods may detect a 
higher number of positives, but methods detecting genetic material do not distinguish between 
viable and non-viable bacteria. Additionally, all specimens were sampled by swabbing; 
meaning a small amount of fecal material was collected. In asymptomatic individuals, normally 
low numbers of bacteria are shedded in the feces and sampling larger quantities may have 
detected more positive samples. The Copan FecalSwabTM (Copan Diagnostics Inc.) sampling 
system was chosen due to the fact that the transport media had been used in a similar study 
(Ngotho et al., 2006) as well as the system being validated with the rotavirus dipstick test 
(Castriciano and Leclipteux, 2009).  
When analysing bacteria from wild animals for antibiotic resistance a pattern is seen: animals 
living in close proximity to human settlements tend to harbour a higher number of resistant 
bacteria (Allen et al., 2010). In the present study three out of 10 C. jejuni showed in vitro 
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resistance to ciprofloxacin, which is a broad-spectrum, bacteriocidal, 2nd generation 
fluoroquinolone that hinders bacterial cell division by inhibiting the enzyme DNA gyrase. This 
is one of the drugs of choice to treat campylobacteriosis in humans (CDC, 2013), but clinical 
resistance is a known problem. Resistance to fluoroquinolones in Campylobacter spp. is most 
often due to mutations in gyrA gene that is partly codes for DNA gyrase (Aarestrup and 
Engberg, 2001). The same three C. jejuni were also resistant to nalidixic acid, another 
quinolone. In previous resistance testing of human Campylobacter spp. samples in Sri Lanka, 
38 % and 69 % were resistant to ciprofloxacin and nalidixic acid, respectively (Cooray and 
Perera, 2007). The primate bacterial strains in the present study are hence less prevalently 
resistant to ciprofloxacin and nalidixic acid than in previously detected human strains. 
Additionally, these three C. jejuni strains were also in vitro resistant to tetracycline. 
Unfortunately, there is no information on tetracycline resistance in human Campylobacter spp. 
strains in Sri Lanka (Cooray and Perera, 2007). Tetracycline resistance in C. jejuni and C. coli 
is mediated through a ribosomal protecting gene, tet(O), that may be self-transmissible on 
plasmids. Probably this gene was historically transferred through horizontal gene transfer from 
Gram-positive bacteria (Aarestrup and Engberg, 2001). The ampicillin resistance seen in both 
C. jejuni and C. coli strains in the present study is likely mediated by the production of β-
lactamases, which is seen in a large proportion of C. coli and C. jejuni (Aarestrup and Engberg, 
2001).  
MIC-distributions for colistin and sulfamethoxazole are reported in this study, despite a lack of 
reported ECOFF-values. Campylobacter spp. have to the author’s knowledge not been reported 
as intrinsically resistant to these antibiotics. All C. jejuni isolates displayed MIC-values for 
colistin that were not quantifiable by the used VetMICTM panel. This indicates resistance 
against the drug in spite of the absence of established ECOFF-values, since the panels are 
adapted to expected MIC-values in Gram-negative bacteria. According to Biswas et al (2012), 
the susceptibility to colistin varies in Campylobacter spp. and the value in reporting MIC-
distributions can therefore be argued for, especially considering the globally emerging bacterial 
resistance against this drug. Similarly, despite ECOFF-values being available for 
sulfamethoxazole, resistance genes and various resistance mechanisms have been described 
(Gibreel and Skold (1999) and these genes are not present in all isolates. When comparing the 
MIC-values of the analysed strains to the ECOFF-value for E. coli – another Gram-negative 
enteric bacterium – it appears likely that all the C. jejuni strains are resistant to colistin and that 
four of the isolates were also resistant to sulfamethoxazole.  
Further studies investigating the characteristics of – and relationship between – the strains of 
Campylobacter spp. and Salmonella spp. that affect humans, domestic animals and free-ranging 
primates in Sri Lanka would be an interesting continuation of this study. A One Health approach 
would entail screening for these bacteria in humans, domestic animals, non-human primates 
and the environment they share. To strengthen the data, studies would ideally include analysing 
a larger sample size originating from several non-human primate troops, allowing for a 
comparison of the prevalence of the bacteria in troops with varying human contact. This could 
shed light on whether urban non-human primates indeed share bacterial strains with humans to 
a greater extent than those with less contact. The role of non-human primates in the 
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epidemiology of Campylobacter spp. and Salmonella spp. in Sri Lanka remains unknown. This 
study has shown that both bacteria species are present in free-ranging non-human primates with 
close human contact. Long-term studies could bring more information about the epidemiology 
and dynamics of these zoonotic enteric bacteria in Sri Lanka and what role the non-human 
primates play. 
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